Ezetimibe Tablet
Product Images NDC 16714-813

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ezetimibe (NDC 16714-813). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label.principal Display Panel (10 mg (30 Tablets Bottle))

Label for Ezetimibe Tablets USP 10 mg oral tablets, containing 30 tablets per package. The label includes the NDC number 16714-813-01 and indicates the product is manufactured for NorthStar Rx LLC. It specifies storage instructions, dosage information, and the product is a product of India. Manufacturer details include Aurobindo Pharma Limited.*

FDA Label Image

Structure (Ezetimibe Str)

Chemical structure of Ezetimibe shown with aromatic rings, fluorine atoms, hydroxyl groups, and a beta-lactam ring, illustrating the molecular framework of the active ingredient Ezetimibe.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.